JOSD1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.384600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.829600E-01
Normal-vs-Stage2
5.052000E-01
Normal-vs-Stage3
8.003200E-01
Normal-vs-Stage4
2.216600E-01
Stage1-vs-Stage2
2.495400E-01
Stage1-vs-Stage3
8.906600E-01
Stage1-vs-Stage4
2.045400E-01
Stage2-vs-Stage3
2.667200E-01
Stage2-vs-Stage4
7.021200E-01
Stage3-vs-Stage4
1.953450E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.972200E-01
Normal-vs-AfricanAmerican
2.538200E-01
Normal-vs-Asian
6.009800E-01
Caucasian-vs-AfricanAmerican
6.369800E-02
Caucasian-vs-Asian
6.912200E-01
AfricanAmerican-vs-Asian
2.703200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.836600E-01
Normal-vs-Female
5.959800E-01
Male-vs-Female
7.142000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.027000E-01
Normal-vs-Age(41-60Yrs)
2.978200E-01
Normal-vs-Age(61-80Yrs)
7.838200E-01
Normal-vs-Age(81-100Yrs)
7.511400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.672050E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.423600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.632600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.330240E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.517660E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.541790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.745000E-01
Normal-vs-Daily Drinker
9.758000E-01
Normal-vs-Weekly Drinker
4.984800E-01
Normal-vs-Occasional Drinker
5.618000E-01
Normal-vs-Social Drinker
6.360200E-01
Non Drinker-vs-Daily Drinker
7.064600E-01
Non Drinker-vs-Weekly Drinker
3.076400E-01
Non Drinker-vs-Occasional Drinker
3.799200E-01
Non Drinker-vs-Social Drinker
6.457400E-01
Daily Drinker-vs-Weekly Drinker
2.507400E-01
Daily Drinker-vs-Occasional Drinker
2.890200E-01
Daily Drinker-vs-Social Drinker
4.767600E-01
Weekly Drinker-vs-Occasional Drinker
8.458200E-01
Weekly Drinker-vs-Social Drinker
5.498600E-01
Occasional Drinker-vs-Social Drinker
6.838000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.365600E-01
Normal-vs-Grade 2
8.470800E-01
Normal-vs-Grade 3
9.071600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.678800E-03
Grade 1-vs-Grade 3
3.924400E-02
Grade 1-vs-Grade 4
9.365600E-01
Grade 2-vs-Grade 3
1.807230E-01
Grade 2-vs-Grade 4
8.470800E-01
Grade 3-vs-Grade 4
9.071600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.154200E-01
Normal-vs-NonDiabetic
6.633400E-01
Diabetic-vs-NonDiabetic
5.180800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.857560E-01
Normal-vs-NoPancreatitis
7.535600E-01
Pancreatitis-vs-NoPancreatitis
4.702400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.291600E-01
Normal-vs-N1
4.925200E-01
N0-vs-N1
3.430100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.119400E-01
Normal-vs-TP53-NonMutant
7.728800E-01
TP53-Mutant-vs-TP53-NonMutant
2.220800E-04
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
